Combination products: modernizing the regulatory paradigm
Nature Reviews Drug Discovery 16, 513 (2017).
doi:10.1038/nrd.2017.66
Authors: Nina L. Hunter & Rachel E. Sherman
New opportunities to develop innovative — and often complex — products that combine drugs, devices and/or biological components are rapidly emerging, raising questions about how such products should be regulated. Here, we discuss the ongoing efforts of the FDA to develop a modern, transparent, flexible
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Nina L. Hunter Rachel E. Sherman Tags: Comment Source Type: research
More News: Drugs & Pharmacology